Endocrine therapy for the treatment of postmenopausal women with breast cancer.

@article{HarichandHerdt2009EndocrineTF,
  title={Endocrine therapy for the treatment of postmenopausal women with breast cancer.},
  author={Seema Harichand-Herdt and Amelia B. Zelnak and Ruth M O'regan},
  journal={Expert review of anticancer therapy},
  year={2009},
  volume={9 2},
  pages={187-98}
}
The treatment of women with estrogen receptor-positive breast cancer has advanced significantly in the past decade. Tamoxifen was the gold standard hormonal therapy for breast cancer until the introduction of aromatase inhibitors and fulvestrant. Many of these new treatments are useful only for patients who are postmenopausal. There are data to support the use of these new agents both in the metastatic and adjuvant settings. Here, we briefly review the recent clinical trials supporting the use… CONTINUE READING

From This Paper

Topics from this paper.
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…